Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797272 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797266 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797168 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797262 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7800317 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797224 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797176 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797267 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7797230 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 | |
| SCHEMBL7801540 | 1.00 | DNM1 (0.41) | DNM1USP2GPR84SPHK1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0854708-B1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-12-12 | — | — | EP | disclosed |
| US-6177469-B1 | ANTIUTOR AGENTS; AUTOIMMUNE DISEASES | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-01-23 | — | — | US | disclosed |
| US-6080734-A | Liponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agents | ROCHE DIAGNOSTIC GMBH (DE) | 2000-06-27 | — | — | US | disclosed |
| EP-0854708-A1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | Roche Diagnostics GmbH (DE) | 1998-07-29 | — | — | EP | disclosed |
| US-5756711-A | Phospholipid derivatives of nucleosides and their use as anti-viral medicaments | BOEHRINGER MANNHEIM GMBH (DE) | 1998-05-26 | — | — | US | disclosed |
| WO-1997014410-A1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-04-24 | — | — | WO | disclosed |
| EP-0654036-B1 | LIPONUCLEOTIDES OF SECO-NUCLEOSIDES, THEIR PREPARATION AND THEIR USE AS ANTI-VIRAL DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-04-23 | — | — | EP | disclosed |
| EP-0706530-A1 | LIPONUCLEOTIDES OF DESOXYNUCLEOSIDES, THEIR PREAPARATION AND THEIR USE AS ANTI-VIRAL DRUGS | Roche Diagnostics GmbH (DE) | 1996-04-17 | — | — | EP | disclosed |
| WO-1995001362-A1 | LIPONUCLEOTIDES OF DESOXYNUCLEOSIDES, THEIR PREAPARATION AND THEIR USE AS ANTI-VIRAL DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1995-01-12 | — | — | WO | disclosed |
| EP-0545966-B1 | NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PREPARATION AND THEIR USE AS ANTIVIRAL DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1994-11-23 | — | — | EP | disclosed |
| US-5158942-A | PROCESS OF USING PHOSPHOLIPID DERIVATIVES TO INHIBIT MULTIPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS | BOEHRINGER MANNHEIM GMBH (DE) | 1992-10-27 | — | — | US | disclosed |